Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study

OBJECTIVE: To compare the humoral response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with multiple sclerosis (MS) receiving different disease-modifying treatments (DMTs). METHODS: Patients with MS with coronavirus disease 2019 (COVID-19) and available a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Lanotte, Livia, Fleury, Marie-Celine, Collongues, Nicolas, de Seze, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362343/
https://www.ncbi.nlm.nih.gov/pubmed/34321333
http://dx.doi.org/10.1212/NXI.0000000000001055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362343/
https://www.ncbi.nlm.nih.gov/pubmed/34321333
http://dx.doi.org/10.1212/NXI.0000000000001055

Ejemplares similares